We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News   Feb 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

 
 
 

RELATED ARTICLES

Cancer Cells Switch Sugar for Fatty Acids to Spread Around the Body

News

Scientists have uncovered a crucial change in cancer cells that allows them to spread around the body – by switching from sugar to fatty acids to fuel their growth.

READ MORE

Anticancer Drug Disguises Itself As Fat

News

A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors.

READ MORE

“Slug” Keeps Breast Stem Cell Health in Check

News

A transcription factor called "Slug" keeps breast cells healthy by regulating both stem cell activity and repair of DNA damage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE